Cargando…
The randomised clinical trial and the hazard ratio – medical research’s Emperor’s New Clothes?
As the enthusiasm for individualized treatment and targeted therapies continues to gain momentum, it seems timely to re-assess whether our current research tools are fit for purpose. Randomized Clinical Trials compare groups of patients, the Hazard Ratio is a ‘group summary statistic’, and modeling...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003285/ https://www.ncbi.nlm.nih.gov/pubmed/24731512 http://dx.doi.org/10.1186/1471-2407-14-260 |